BBT
Beacon Financial Corp.
BBT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has a slight edge over BBT overall, supported by stronger modeled upside and lower modeled downside.
BBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BBT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BBT.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.4x | $30.68 | — |
| Cheap | 9.8x | $26.30 | -14% |
| Current | 11x | $30.68 | — |
| Fair | 14x | $37.89 | +24% |
| Expensive | 24x | $65.84 | +115% |
Historical ranges are pointers, not guarantees.
BBT has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BBT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect BBT's profitability to improve, with its earnings and revenue holding steady.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over BBT on the outlook, with more favorable earnings and revenue expectations.
BBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.26 | +21% |
| Q3 2026 | $2.69 | +142% |
| Q2 2026 | $1.39 | -46% |
| Q1 2026 | $1.28 | -48% |
| Q4 2025 | $1.29 | -10% |
| Q3 2025 | $1.11 | +17% |
| Q2 2025 | $2.56 | +392% |
| Q1 2025 | $2.47 | +394% |
| Q4 2024 | $1.44 | -10% |
BBT earned $2.69 per share over the past year, up 142% from the year before. Its recent earnings include one-off gains.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over BBT on earnings, with more consistent year-over-year improvement.
BBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $223.2M | +54% |
| Q2 2026 | $219.2M | +93% |
| Q1 2026 | $214.7M | +94% |
| Q4 2025 | $225.7M | +105% |
| Q3 2025 | $145M | +15% |
| Q2 2025 | $113.7M | +4.6% |
| Q1 2025 | $110.4M | +99% |
| Q4 2024 | $110.2M | +38% |
BBT has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +86 points |
| Q2 2026 | 40% | +3.2 points |
| Q1 2026 | 31% | -0.6 points |
| Q4 2025 | 33% | +9.2 points |
| Q3 2025 | -50% | -88 points |
| Q2 2025 | 37% | +7.8 points |
| Q1 2025 | 31% | +79 points |
| Q4 2024 | 24% | +32 points |
BBT has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
BBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $95.5M | +$99.1M |
| Q2 2026 | $64.1M | +77% |
| Q1 2026 | -$13.8M | -170% |
| Q4 2025 | $159.6M | +381% |
| Q3 2025 | -$3.6M | -108% |
| Q2 2025 | $36.3M | +5.5% |
| Q1 2025 | $19.9M | +200% |
| Q4 2024 | $33.2M | -35% |
BBT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +58.1K shares |
| 1 year | -4% | -3.5M shares |
| 3 years | +94% | +40.7M shares |
| 5 years | +72% | +35.3M shares |
| Available history | +66% | +33.3M shares |
BBT has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $2,000 |
| Q3 2024 | $1,000 |
| Q2 2024 | $13.5M |
| Q1 2024 | $4M |
| Q4 2023 | $6.7M |
| Q3 2023 | $3.6M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
BBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | 1.8x | Healthy |
BBT's net debt is about 1.8 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like BBT.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
BBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 65.5 | Neutral |
BBT's weekly RSI is 54 (neutral) and its Stochastic is 66 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BBT PE vs Financial Services Sector
| Metric | BBT | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 12% below |
| PE % | 36 | 63 | 27 pts below |
BBT has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
BBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.2 | 5.2% above |
| 20 week MA | $30.3 | 1.2% above |
| 50 week MA | $29.6 | 3.7% above |
| 100 week MA | $27.8 | 11% above |
| 200 week MA | $25.9 | 19% above |
BBT has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.8 | $17.6 | -46% |
| 2021 | $17.6 | $28.4 | +61% |
| 2022 | $28.4 | $29.6 | +4.3% |
| 2023 | $29.6 | $24.8 | -16% |
| 2024 | $24.8 | $28.3 | +14% |
| 2025 | $28.3 | $26.9 | -4.9% |
| 2026 YTD | $26.9 | $30.7 | +14% |
BBT has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.